IGF2BP2 and thyroid gland carcinoma: To identify potential downstream effectors of IGF2BP2-driven dedifferentiation, we performed an intersection analysis of the DEGs across these two contrasting thyroid cancer models, TPC1-OE and CAL62-KD.